Arbutus Biopharma Corp (ABUS)

Net Receivables

$179.74M

Quarterly · Period ending: · USD

ABUS logo

ABUS Net Receivables

Latest reported$179.74M
ABUS Quarterly Net Receivables ($1.17M → $179.74M)
High-resolution chart · PNG

ABUS net receivables history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arbutus Biopharma Corp Net Receivables — Quarterly (USD)
Period endingNet Receivables (USD)
179,742,000
1,312,000
1,747,000
905,000
1,024,999
1,182,000
2,409,000
1,608,000
2,067,000
2,139,000
1,776,000
2,771,000
3,214,000
2,664,000
1,352,000
1,835,000
1,970,000
1,313,000
899,000
1,667,000
1,298,000
1,265,000
1,312,000
1,075,000
1,108,000
1,072,000
1,204,000
2,488,000
1,531,000
1,214,000
1,431,000
880,000
1,664,000
1,189,000
870,000
1,134,000
1,330,000
8,314,000
694,000
671,000
732,000
714,000
1,382,000
2,698,000
6,710,000
6,238,000
2,527,000
2,246,000
539,000
1,972,000
369,000
5,110,449
4,718,690
4,894,774
3,458,647
2,090,185
2,139,133
2,776,067
1,044,121
2,519,073
5,010,506
3,831,571
3,721,713
2,703,695
1,183,186
1,009,381
1,273,065
1,253,632
1,377,656
1,153,250
519,670
2,213,027
2,544,006
687,092
1,837,967
2,573,107
1,167,284
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.